Filtros de búsqueda

Lista de obras de

Antitumor effects of the GM3(Neu5Gc) ganglioside-specific humanized antibody 14F7hT against Cmah-transfected cancer cells

scientific article published on 09 July 2019

Engineered tobacco etch virus (TEV) protease active in the secretory pathway of mammalian cells

artículo científico publicado en 2015

Expression and Functional Role of TRPV4 in Bone Marrow-Derived CD11c+ Cells

scientific article published on 10 July 2019

Gangliosides, Ab1 and Ab2 antibodies I. Towards a molecular dissection of an idiotype-anti-idiotype system

artículo científico publicado en 2006

Idiotypes as immunogens: facing the challenge of inducing strong therapeutic immune responses against the variable region of immunoglobulins ⬇️

artículo científico publicado el 9 de noviembre de 2012

In vivo site-specific biotinylation of proteins within the secretory pathway using a single vector system

artículo científico publicado en 2008

Molecular subtyping of metastatic melanoma based on cell ganglioside metabolism profiles.

artículo científico publicado en 2014

Nimotuzumab, an antitumor antibody that targets the epidermal growth factor receptor, blocks ligand binding while permitting the active receptor conformation

artículo científico publicado en 2009

Structure of the Fab fragment of the anti-murine EGFR antibody 7A7 and exploration of its receptor binding site

artículo científico publicado en 2011

Switching on cytotoxicity by a single mutation at the heavy chain variable region of an anti-ganglioside antibody ⬇️

artículo científico publicado el 1 de abril de 2011

The Citrus Flavonoid Hesperetin Has an Inadequate Anti-Arrhythmic Profile in the ΔKPQ NaV1.5 Mutant of the Long QT Type 3 Syndrome

artículo científico publicado en 2020

The citrus flavanone hesperetin preferentially inhibits slow-inactivating currents of a long QT syndrome type 3 syndrome Na+ channel mutation

scientific article published on 27 March 2019

Very small size proteoliposomes derived from Neisseria meningitidis: An effective adjuvant for antigen-specific cytotoxic T lymphocyte response stimulation under leukopenic conditions ⬇️

artículo científico publicado el 3 de marzo de 2012

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda